ArticleTransgenic research2014
Rapid identification of targeted transgene integrations in ES cells by fluorescence detection.
Article in Transgenic research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The generation of transgenic animals with a gain-of-function mutation is commonly achieved by procedures based on random DNA integration. The resulting transgenic founder lines are unique, not reproducible and have variable expression patterns. In contrast, the targeted integration of transgenes into a predetermined neutral genomic position solves most of the inadequacies of random integration methods. However, homologous recombination (HR) in mouse embryonic stem cells (ESCs) currently requires careful design of the targeting vector and a laborious procedure to identify clones with the correct insertion event. Here, we introduce a feasible strategy that employs a heterozygous double fluorescent reporter ESC line for simple identification of a knock-in HR event via detection of endogenous fluorescence expression. Following positive selection using antibiotics, the system offers a second selection step to identify targeted clones by the loss of one of two fluorescence reporters in lieu of the time consuming Southern blotting and PCR analysis routinely applied in conventional targeting experiments. Moreover, the method allows for the simple detection of chimerism (negating the need for appropriate coat colour combinations) and enables the early detection of germline transmission by fluorescence reporter expression in F1 neonates.
Indexed as
Identifiers
24482264What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.